COMMUNIQUÉS West-GlobeNewswire

Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
28/07/2026
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a [...]
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
28/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that the Company will report second quarter 2026 financial results after market close [...]
National Center for Cannabis Research and Education at the University of Mississippi and Southern Sky Brands Launch CBD Sleep Study
28/07/2026
OXFORD, Miss. and CANTON, Miss., July 28, 2026 (GLOBE NEWSWIRE) -- The National Center for Cannabis Research and Education (NCCRE) at the University of Mississippi and Southern Sky Brands have announced a collaborative [...]
The Cooperative of American Physicians Promotes Simon Russell to Vice President of Underwriting
28/07/2026
LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP), a leading provider of medical malpractice coverage, announced the promotion of Simon Russell to Vice President of [...]
Healthcare Executives Signal Growing Strategic Value of Laboratory Services, Siemens Healthineers Survey Finds
28/07/2026
New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and Clinical Lab Expo kicks off, Siemens Healthineers will unveil [...]
Pennant Announces Second Quarter 2026 Earnings Release and Call
28/07/2026
EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
28/07/2026
BERWYN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a full-spectrum pharmacy solutions provider rooted in specialty pharmacy expertise, today announces the appointment of Johanna van Nijkerk as vice president [...]
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28/07/2026
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis ( 3) at constant exchange rates (CER); adverse FX impact of € 34.5 million (-2.6%) EBITDA ( 1) of € 540.2 [...]
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
28/07/2026
Solid revenue 1 trajectory at +9.7% in H1, with Q2 at +8.7% Increasing profitability, with Adj. Operating Profit 1,2 +15% Group’s revenue grew 9.7% in H1 at constant exchange rates 1 , with Q2 at +8.7% Retail comparable [...]
EssilorLuxottica: Résultats T2/S1 2026 - Trajectoire solide du chiffre d’affaires à +9,7 % au S1, avec un T2 à +8,7 %. Rentabilité en hausse, avec un résultat opérationnel ajusté progressant de +15 %.
28/07/2026
Trajectoire solide du chiffre d’affaires 1 à +9,7 % au S1, avec un T2 à +8,7 % Rentabilité en hausse, avec un résultat opérationnel ajusté 1,2 progressant de +15 % Chiffre d’affaires du Groupe en hausse de +9,7 % au S1 [...]
Eurobio Scientific: Premier semestre 2026, Continuation de la transformation stratégique
28/07/2026
PREMIER SEMESTRE 2026, CONTINUATION DE LA TRANSFORMATION STRATEGIQUE Progression du chiffre d’affaires semestriel de 5% à 84,5 M€ Continuation de la stratégie du Groupe : Produits propriétaires : 37% du Chiffre d’ [...]
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
28/07/2026
FIRST HALF OF 2026, CONTINUATION OF THE STRATEGIC TRANSFORMATION First-half revenue up 5% to €84.5 million Continuation of the Group’s strategy: Proprietary products: 37% of revenue International expansion: 47% of [...]
North Texas Plastic Surgery’s Dr. Sacha Obaid Named to Newsweek’s America’s Best Plastic Surgeons 2025 List
28/07/2026
Recognition spans five procedure categories, including breast augmentation, liposuction, rhinoplasty, eyelid surgery and tummy tuck SOUTHLAKE, Texas, July 28, 2026 (GLOBE NEWSWIRE) -- North Texas Plastic Surgery [...]
SodaSlim Introduces a Gummy Supplement Format as Part of Its Portfolio Expansion
28/07/2026
SodaSlim Gummies expand the company’s product portfolio following a coordinated development cycle covering formulation design, production planning, packaging preparation and quality review. New York City, July 28, 2026 [...]
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
28/07/2026
A featured menopause telehealth option is now available to women exploring DARE to PLAY™, advancing Daré’s strategy to build a trusted women’s health ecosystem spanning products, education and access to care [...]
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
28/07/2026
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
28/07/2026
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
28/07/2026
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28/07/2026
Brings nearly three decades of leadership spanning NMIBC, corporate strategy and business development to help advance NDV-01 and support the Company's long-term growth and value creation. CORAL GABLES, Fla., July 28, [...]

Pages